Astria Therapeutics Forecast, price target & analysts
Astria Therapeutics Target price 2026 - Analyst rating & recommendation
Astria Therapeutics Classifications & Recommendation:
Astria Therapeutics Price Target
| Target Price | $13.26 |
| Price | $12.89 |
| Potential |
2.87%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target Astria Therapeutics 2027 .
The average Astria Therapeutics target price is $13.26.
This is
2.87%
register free of charge
$36.75
185.10%
register free of charge
$13.13
1.86%
register free of charge
|
|
| A rating was issued by 14 analysts: 6 Analysts recommend Astria Therapeutics to buy, 8 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Astria Therapeutics stock has an average upside potential 2027 of
2.87%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.00 | 8.74 |
8 Analysts have issued a sales forecast Astria Therapeutics 2025 . The average Astria Therapeutics sales estimate is
This results in the following potential growth metrics:
10 Astria Therapeutics Analysts have issued a net profit forecast 2025. The average Astria Therapeutics net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.68 | -2.20 |
| 30.58% | 30.95% | |
| P/E | negative | |
| EV/Sales | 58.14 |
10 Analysts have issued a Astria Therapeutics forecast for earnings per share. The average Astria Therapeutics EPS is
This results in the following potential growth metrics and future valuations:
Astria Therapeutics...
Current Astria Therapeutics Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Nov 12 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Oct 16 2025 |
| Wedbush |
Locked
➜
Locked
|
Locked | Oct 15 2025 |
| JMP Securities |
Locked
➜
Locked
|
Locked | Oct 15 2025 |
| Jefferies |
Locked
➜
Locked
|
Locked | Oct 14 2025 |
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Sep 17 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 17 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Nov 12 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Oct 16 2025 |
|
Locked
Wedbush:
Locked
➜
Locked
|
Oct 15 2025 |
|
Locked
JMP Securities:
Locked
➜
Locked
|
Oct 15 2025 |
|
Locked
Jefferies:
Locked
➜
Locked
|
Oct 14 2025 |
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Sep 17 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 17 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
